Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials

Related Attributes

Product details

Moxifloxacin Hydrochloride Powder Usage and Synthesis.

Moxifloxacin Hydrochloride is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis caused by Staphylococcus aureus, H. influenzae, pneumococcus, Moraxella catarrhalis, and other diseases. caused by Staphylococcus aureus, H. influenzae, pneumococcus, Moraxella catarrhalis, and S. pneumoniae.

Fluoroquinolone antimicrobials, and other antimicrobials have been used in the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis.

Moxifloxacin Hydrochloride Powder is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and for the prevention and treatment of chronic bronchitis.

Moxifloxacin Hydrochloride Raw Materials is used for the treatment of genitourinary infections, acute sinusitis. The efficacy is remarkable and the adverse effects are small. The efficacy is remarkable and the adverse effects are small.

The efficacy is remarkable and the adverse effects are small.

Uses and functions of Moxifloxacin Hydrochloride Powder.

Moxifloxacin Hydrochloride Powder is an antibiotic used to treat bacterial infections of the lungs, paranasal sinuses, skin, and abdominal cavity in adults.

UsesFourth generation ultra-broad-spectrum quinolone antibiotic uses Fluoroquinolone antimicrobials,

Moxifloxacin Hydrochloride is used for the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, genitourinary infections, and acute sinusitis. It has significant therapeutic efficacy and low adverse effects.

Pharmacological Effects of Moxifloxacin Hydrochloride Powder.

The mechanism of action and in vitro antimicrobial spectrum of this product are similar to other fluoroquinolones, but the antimicrobial activity against gram-positive bacteria and anaerobes is similar to that of trovafloxacin (trovafloxacin) and superior to some older varieties.

Few Gram-positive bacteria were resistant to moxifloxacin hydrochloride or resistance developed very slowly compared to other fluoroquinolones, and cross-resistant bacteria were found among Gram-negative bacteria and enterococci in comparison to other fluoroquinolones.

However, it is effective against at least Staphylococcus aureus isolate beads grlA, grlB, gyrA or gyrB. 0.5-2mg/L of this product can inhibit ciprofloxacin-resistant S. aureus, which are ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin, and moxifloxacin, according to MICs in descending order.

Production method of Moxifloxacin Hydrochloride Powder.

Why choose us?

HRK Factory

About Shipping